[23 April 2013]
Products Affected - Description
Naloxone 0.4 mg/mL Injection, Hospira
10 mL vials (NDC 00409-1219-01)
Reason for the Shortage
- Endo discontinued its Narcan 0.02 mg/mL 2 mL ampules, 1 mg/mL 10-mL multidose vial, and 2-mL ampule presentations in 2005. The company discontinued their 0.4 mg/mL presentations September, 2006. Endo would not provide a reason for the discontinuations.
- Abbott discontinued naloxone 0.02 mg/mL 2 mL ampules and vials in 2001. The company would not provide a reason for the discontinuation.
- There are no manufacturers of naloxone 0.02 mg/mL strength.
- Hospira has naloxone on shortage due to manufacturing delays.
- Amphastar changed NDC numbers in spring, 2012.
Available Products
Naloxone 1 mg/mL Injection, Amphastar
2 mL Mini-I-Jet syringes with needles (NDC 76329-1469-05)
2 mL Luer-Jet syringes without needles (NDC 76329-3369-01)
Naloxone 0.4 mg/mL Injection, Hospira
1 mL vials (NDC 00409-1215-01)
1 mL Carpuject syringe (NDC 00409-1782-69)
Estimated Resupply Dates
Hospira has naloxone 0.4 mg/mL 10 mL vials on intermittent back order and the company is releasing product as it becomes available.
Updated
April 23, 2013; March 5, 2013; January 21, 2013; December 21, 2012; December 10, 2012; November 19, 2012; October 11, 2012; October 5, 2012; September 28, 2012; August 16, 2012; July 3, 2012; June 27, 2012; June 4, 2012; May 24, 2012; May 18, 2012; May 14, 2012; May 10, 2012; April 11, 2012; March 29, 2012; March 8, 2012; February 10, 2012; December 13, 2011; November 15, 2011; October 31, 2011; October 20, 2011; October 11, 2011; September 27, 2011; September 2, 2011, University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins